EUVIMEDEUVIMED entdecken
Crossref

The Dopaminergic D3 System and Incretin Therapies: New Perspectives on Reducing Addictive Behaviors

Oana Cristina Cretu, Teodora Cojocaru

Bulletin of Integrative Psychiatry · 15.06.2026 · 109 (2) · 117-123

DOI: 10.36219/bpi.2026.2.10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Integrative Psychiatry, online erschienen am 15.06.2026. Verfasst von Oana Cristina Cretu und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Addictive behaviors, including both substance use disorders and behavioral addictions, represent a major public health challenge due to their high prevalence and significant relapse rates. The mesolimbic dopaminergic system plays a central role in the neurobiological mechanisms of reward, motivation, and craving, with the dopaminergic D3 receptor being considered one of the most relevant targets involved in the development and maintenance of addictive behaviors. In recent years, incretin therapies, especially glucagon-like peptide-1 (GLP-1) receptor agonists, have attracted attention because of their observed effects on consumption behaviors and reduction of the reward-seeking drive. The D3 receptor, located predominantly in limbic structures, is involved in craving, sensitization and relapse processes. The available data indicate the existence of functional interactions between the incretin system and dopaminergic neurotransmission, which may contribute to reducing the consumption of alcohol, nicotine, and other substances, as well as certain non-substance compulsive behaviors. The interaction between the dopaminergic D3 system and incretin signaling represents an emerging field with significant therapeutic potential in the treatment of addictions. Incretin therapies could offer an innovative approach to reducing craving and reward-seeking behaviors; however, prospective clinical studies and additional neurobiological investigations are required to clarify the mechanisms involved and their clinical relevance.

Zitieren

APA

Cretu, O. C., & Cojocaru, T. (2026). The Dopaminergic D3 System and Incretin Therapies: New Perspectives on Reducing Addictive Behaviors. Bulletin of Integrative Psychiatry, 109(2), 117-123. https://doi.org/10.36219/bpi.2026.2.10

Vancouver

Cretu OC, Cojocaru T. The Dopaminergic D3 System and Incretin Therapies: New Perspectives on Reducing Addictive Behaviors. Bulletin of Integrative Psychiatry. 2026;109(2):117-123. doi:10.36219/bpi.2026.2.10

BibTeX
@article{Cretu2026,
  author = {Cretu, Oana Cristina and Cojocaru, Teodora},
  title = {The Dopaminergic D3 System and Incretin Therapies: New Perspectives on Reducing Addictive Behaviors},
  journal = {Bulletin of Integrative Psychiatry},
  year = {2026},
  volume = {109},
  number = {2},
  pages = {117--123},
  doi = {10.36219/bpi.2026.2.10}
}
Kostenlos starten →